Neurol. praxi. 2021;22(3):242-247 | DOI: 10.36290/neu.2020.049

Congenital myopathy associated with RYR1 gene mutation (case report)

MUDr. Patrícia Balážová, MUDr. Karin Viestová, MUDr. Miriam Kolníková, PhD.
Klinika detskej neurológie LF UK a NÚDCH, Bratislava

Congenital myopathies are a heterogenous group of genetic neuromuscular disorders characterized by variable phenotype and characteristic histopathological picture. The clinical features of patients are muscle weakness and hypotonia, which is often present at birth and in the early months of life (floppy baby syndrome). The clinical course of disease is static or slowly progressive. In the past, diagnose of congenital myopathy was based on muscle biopsy, which has been replaced by methods of genetic testing. In our case report we presented a case of 15 years-old boy with a manifestation of hypotonic syndrome in the neonatal period, followed by difficulty walking and loss of ambulation.

Keywords: congenital myopathies, neuromuscular disorders, diagnostics, therapy.

Received: May 18, 2020; Revised: May 26, 2020; Accepted: May 26, 2020; Prepublished online: May 26, 2020; Published: October 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Balážová P, Viestová K, Kolníková M. Congenital myopathy associated with RYR1 gene mutation (case report). Neurol. praxi. 2021;22(3):242-247. doi: 10.36290/neu.2020.049.
Download citation

References

  1. Amburgey K, Bailey A, Hwang JH, Tarnopolsky MA, Bonnemann CG, Medne L, Mathews KD, Collins J, Daube JR, Wellman GP, Callaghan B, Clarke NF, Dowling JJ. Genotype-phenotype correlations in recessive RYR1-related myopathies. Orphanet J Rare Dis. 2013; 8: 117. Go to original source... Go to PubMed...
  2. Cassandrini D, Trovato R, Rubegni A, Lenzi S, Fiorillo C, Baldacci J, Minetti C, Astrea G, Bruno C, Santorelli FM; Italian Network on Congenital Myopathies: Congenital myopathies: clinical phenotypes and new diagnostic tools. Ital J Pediatr. 2017; 43(1): 101. Go to original source... Go to PubMed...
  3. Claeys KG. Congenital myopathies: an update. Dev Med Child Neurol. 2020; 62: 297-302. Go to original source... Go to PubMed...
  4. Ehler E, (Ed.). Neuromuskulárni choroby v kazuistikách. Praha: Maxdorf 2019: 240 s.
  5. Kraus J, Vajsar J, Zámečník J. Kongenitálni myopatie. Neurol. praxi. 2012; 13(4): 188-194.
  6. Lawal TA, Todd JJ, Meilleur KG. Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches. Neurotherapeutics. 2018; 15(4): 885-899. Go to original source... Go to PubMed...
  7. Meissner G. Regulation of mammalian ryanodine receptors. Frontiers in bioscience: a journal and virtual library. 2002; 7: d2072-80. Go to original source... Go to PubMed...
  8. North KN, Wang CH, Clarke N, Jungbluth H, Vainzof M, Dowling JJ, Amburgey K, Quijano-Roy S, Beggs AH, Sewry C, Laing NG, Bönnemann CG; International Standard of Care Committee for Congenital Myopathies. Approach to the diagnosis of congenital myopathies. Neuromuscul Disord. 2014; 24(2): 97-116. Go to original source... Go to PubMed...
  9. Vojtíšková J. Malignî hypertermie. Pediatr. praxi. 2017; 18(6): 368-372. Go to original source...
  10. Wang CH, Dowling JJ, North K, Schroth MK, Sejersen T, Shapiro F, Bellini J, Weiss H, Guillet M, Amburgey K, Apkon S, Bertini E, Bonnemann C, Clarke N, Connolly AM, Estournet-Mathiaud B, Fitzgerald D, Florence JM, Gee R, Gurgel-Giannetti J, Glanzman AM, Hofmeister B, Jungbluth H, Koumbourlis AC, Laing NG, Main M, Morrison LA, Munns C, Rose K, Schuler PM, Sewry C, Storhaug K, Vainzof M, Yuan N. Consensus statement on standard of care for congenital myopathies. J Child Neurol. 2012; 27(3): 363-382. Go to original source... Go to PubMed...
  11. Witherspoon JW, Meilleur KG. Review of RyR1 pathway and associated pathomechanisms. Acta Neuropathol Commun. 2016; 4(1): 121. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.